Inflammation and cardiac diseases /
Saved in:
| Imprint: | Basel ; Boston : Birkhàˆuser Verlag, c2003. |
|---|---|
| Description: | xiv, 416 p. : ill. (some col.) ; 24 cm. |
| Language: | English |
| Series: | Progress in inflammation research PIR (Series) |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4967830 |
Table of Contents:
- List of contributors
- Introduction
- Inflammation--a new frontier in cardiac disease and therapeutics
- Pathological aspects and inflammation biomarkers in cardiac diseases
- A biomarker of inflammation in cardiovascular diseases
- Inflammation and coronary artery disease
- Inflammatory cells and their metalloproteinases in cardiac diseases
- The role of matrix metalloproteinases in LV remodeling following myocardial infarction
- Matrix metalloproteinases in heart failure: evidence from experimental models
- Inflammatory cytokines in cardiac diseases
- The clinical experience with anti-cytokine therapy in heart failure
- The role of IL-6 and related cytokines in myocardial remodeling and inflammation--implication for cardiac hypertrophy and heart failure
- Toll-like receptors and the cardiovascular system
- The role of IL-6 in experimental and clinical heart failure
- Oxygen and nitrogen reactive radicals in cardiac inflammation and disease
- Myocardial nitric oxide in cardiac remodeling
- Identification and role of inflammatory oxygen free radicals in cardiac ischemia and reperfusion injury
- The immune and complement system and cardiac diseases
- Immune-mediated myocarditis and interleukin-10
- Immunomodulation in heart failure: experimental models
- The role of complement in myocardial inflammation and reperfusion injury
- Inflammatory signaling pathways in cardiac diseases
- The role of immune and inflammatory cytokines in ischemic preconditioning of the heart--identification of novel cardiac cell survival signaling programs
- Stress-activated signals and their role in myocardial ischemia
- p38 MAPK in cardiac remodeling and failure: cytokine signaling and beyond
- Inflammation and myocarditis
- Inflammation and myocarditis
- The inflammatory process in experimental myocarditis
- Nuclear factors in cardiac disease
- Peroxisome proliferator activated receptors, inflammation, the vasculature and the heart
- Chemokines and cardiac diseases
- Role of chemokines in the pathogenesis of congestive heart failure
- Neurohormonal mediators and cardiac inflammation
- The role of endothelin-1 in myocardial inflammation and fibrosis
- Cyclooxygenases and cardiac diseases
- Cyclo-oxygenase-2 and myocardial ischemia
- Inflammation and arrhythmias
- Inflammation as a cause and consequence of atrial fibrillation
- Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases
- Index
